API
ANGO icon

Advisor Partners II’s AngioDynamics ANGO Stock Holding History

Advisor Partners II’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,345
Closed -$142K – 1006
2022
Q4 		$142K Buy
+10,345
New +$144K 0.01% 901

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisor Partners II's ANGO Position: Q1 2023 in Review

Advisor Partners II sold out of AngioDynamics (ANGO) in Q1 2023, closing a stake of 10,345 shares — an estimated $142K sold.

Advisor Partners II first reported a position in ANGO in Q4 2022 and held it in 1 quarter. The position peaked at $142K in Q4 2022. 153 funds tracked by Wall St. Rank hold ANGO as of Q1 2023.

  • Advisor Partners II reported no remaining AngioDynamics position as of Q1 2023 after selling out during the quarter.
  • Advisor Partners II sold 10,345 AngioDynamics shares in Q1 2023, an estimated $142K.
  • Advisor Partners II first reported a position in AngioDynamics in Q4 2022 and held it in 1 quarter.
  • Advisor Partners II's AngioDynamics position peaked at $142K in Q4 2022.
  • 153 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2023.

Based on Advisor Partners II's 13F filing for Q1 2023, filed 15 May 2023.